Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration

Detalles Bibliográficos
Autores principales: Höglund, K., Kern, S., Zettergren, A., Börjesson-Hansson, A., Zetterberg, H., Skoog, I., Blennow, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242951/
https://www.ncbi.nlm.nih.gov/pubmed/30455463
http://dx.doi.org/10.1038/s41398-018-0301-9
_version_ 1783371874180268032
author Höglund, K.
Kern, S.
Zettergren, A.
Börjesson-Hansson, A.
Zetterberg, H.
Skoog, I.
Blennow, K.
author_facet Höglund, K.
Kern, S.
Zettergren, A.
Börjesson-Hansson, A.
Zetterberg, H.
Skoog, I.
Blennow, K.
author_sort Höglund, K.
collection PubMed
description
format Online
Article
Text
id pubmed-6242951
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-62429512018-11-26 Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration Höglund, K. Kern, S. Zettergren, A. Börjesson-Hansson, A. Zetterberg, H. Skoog, I. Blennow, K. Transl Psychiatry Correction Nature Publishing Group UK 2018-11-19 /pmc/articles/PMC6242951/ /pubmed/30455463 http://dx.doi.org/10.1038/s41398-018-0301-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correction
Höglund, K.
Kern, S.
Zettergren, A.
Börjesson-Hansson, A.
Zetterberg, H.
Skoog, I.
Blennow, K.
Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title_full Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title_fullStr Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title_full_unstemmed Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title_short Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
title_sort correction: preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242951/
https://www.ncbi.nlm.nih.gov/pubmed/30455463
http://dx.doi.org/10.1038/s41398-018-0301-9
work_keys_str_mv AT hoglundk correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT kerns correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT zettergrena correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT borjessonhanssona correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT zetterbergh correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT skoogi correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration
AT blennowk correctionpreclinicalamyloidpathologybiomarkerpositivityeffectsontaupathologyandneurodegeneration

Ejemplares similares